AU2003302365A1 - Therapeutic oxidation catalysts - Google Patents

Therapeutic oxidation catalysts

Info

Publication number
AU2003302365A1
AU2003302365A1 AU2003302365A AU2003302365A AU2003302365A1 AU 2003302365 A1 AU2003302365 A1 AU 2003302365A1 AU 2003302365 A AU2003302365 A AU 2003302365A AU 2003302365 A AU2003302365 A AU 2003302365A AU 2003302365 A1 AU2003302365 A1 AU 2003302365A1
Authority
AU
Australia
Prior art keywords
therapeutic
oxidation catalysts
catalysts
oxidation
therapeutic oxidation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003302365A
Inventor
Fiona Fry
Gregory Giles
Claus Jacob
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Exeter Antioxidant Therapeutics Ltd
Original Assignee
Exeter Antioxidant Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exeter Antioxidant Therapeutics Ltd filed Critical Exeter Antioxidant Therapeutics Ltd
Publication of AU2003302365A1 publication Critical patent/AU2003302365A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C391/00—Compounds containing selenium
    • C07C391/02—Compounds containing selenium having selenium atoms bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C395/00—Compounds containing tellurium
AU2003302365A 2002-11-22 2003-11-24 Therapeutic oxidation catalysts Abandoned AU2003302365A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0227348.0A GB0227348D0 (en) 2002-11-22 2002-11-22 Redox catalyst compositions
GB0227348.0 2002-11-22
PCT/GB2003/005095 WO2004047925A2 (en) 2002-11-22 2003-11-24 Therapeutic oxidation catalysts

Publications (1)

Publication Number Publication Date
AU2003302365A1 true AU2003302365A1 (en) 2004-06-18

Family

ID=9948379

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003302365A Abandoned AU2003302365A1 (en) 2002-11-22 2003-11-24 Therapeutic oxidation catalysts

Country Status (3)

Country Link
AU (1) AU2003302365A1 (en)
GB (1) GB0227348D0 (en)
WO (1) WO2004047925A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009144253A1 (en) * 2008-05-29 2009-12-03 Karolinska Institutet Innovations Ab Compounds comprising a 3-pyridinol or 5-pyrimidinol ring having an organoseleno or organotelluro substituent for use as antioxidants
CN103086935B (en) * 2011-10-28 2015-05-20 沈阳药科大学 Diphenyl selenide, diphenyl selenoxide, diphenyl selenone compounds and uses thereof
US11053236B2 (en) 2016-06-21 2021-07-06 The University Of Toledo Substituted isoselenazolone anti-infective, anti-inflammatory, anti-cancer, cytoprotective, neuroprotective, and anti-oxidant agents
CN114057619B (en) * 2020-07-31 2024-03-22 深圳福山生物科技有限公司 Organic selenium compounds and therapeutic uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9200502D0 (en) * 1992-02-20 1992-02-20 Astra Ab NOVEL ANTIOXIDANTS

Also Published As

Publication number Publication date
WO2004047925A3 (en) 2004-10-28
WO2004047925A2 (en) 2004-06-10
GB0227348D0 (en) 2002-12-31

Similar Documents

Publication Publication Date Title
AU2003236906A1 (en) Catalyst
AU2003206700A1 (en) Catalyst
AU2003233738A1 (en) Oxygen reduction catalyst
AU2003243777A1 (en) Multi-zone catalytic converter
AU2003224725A1 (en) Hiv therapeutic
AU2003217740A1 (en) Non-invasive stationary system
AU2003216412A1 (en) Catalyst carriers
AU2003212554A1 (en) Steam-reforming catalytic structures
AUPS044502A0 (en) Novel catalysts and processes for their preparation
AU2003283257A1 (en) Scalp treatment
AU2003283626A1 (en) Catheter
AU2003292403A1 (en) Oxidation catalyst and its preparation
AU2003297207A1 (en) Supported metal catalysts
AU2003247005A1 (en) Therapy combination
AU2003284195A1 (en) Olefin oxide catalysts
AU2003210257A1 (en) Catalytic converter
AU2003245794A1 (en) Glycosaminoglycan-dnase combination therapy
EP1655070A4 (en) Oxidation catalyst
AU2003215150A1 (en) Therapeutic compounds
AU2003263308A1 (en) Catalysts
AU2002258956A1 (en) Ship-in-a-bottle catalysts
AU2003302365A1 (en) Therapeutic oxidation catalysts
AU2003244140A1 (en) Catheter
AU2003225401A1 (en) Dl-hydroxy-alkyl-phenylamides having anticonvulsive activity
AU2003242428A1 (en) Drugs improved in tissue selectivity

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase